Chemical formula: I- Molecular mass: 130.907 g/mol PubChem compound: 167195
Iodide is actively transported by the sodium-iodide symporter (NIS) protein, in thyroid follicular cells. Sodium iodide ¹³¹I is used for the treatment of hyperthyroidism and selected cases of thyroid carcinoma. The beta emission of I 131 is responsible for the therapeutic effect.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V10XA01 | Sodium iodide (131I) | V Various → V10 Therapeutic radiopharmaceuticals → V10X Other therapeutic radiopharmaceuticals → V10XA Iodine (131I) compounds |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| HICON Oral solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Sodium iodide ¹³¹I is an active ingredient of these brands:
United States (US)Lithuania (LT)Romania (RO)Singapore (SG)Spain (ES)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
